ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide

Abstract The RNA binding protein ADAR3 is expressed exclusively in the brain and reported to have elevated expression in tumors of patients suffering from glioblastoma compared to adjacent brain tissue. Yet, other studies have indicated that glioblastoma tumors exhibit hemizygous deletions of the ge...

Full description

Bibliographic Details
Main Authors: Reshma Raghava Kurup, Eimile K. Oakes, Pranathi Vadlamani, Obi Nwosu, Pranav Danthi, Heather A. Hundley
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-17559-4